- Home
- GOVX vs DRRX Comparison
GOVX vs DRRX Comparison
Compare GOVX & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- DRRX
- Stock Information
- Founded
- GOVX 2001
- DRRX 1998
- Country
- GOVX United States
- DRRX United States
- Employees
- GOVX N/A
- DRRX N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- GOVX Health Care
- DRRX Health Care
- Exchange
- GOVX Nasdaq
- DRRX Nasdaq
- Market Cap
- GOVX 23.8M
- DRRX 26.4M
- IPO Year
- GOVX N/A
- DRRX 2000
- Fundamental
- Price
- GOVX $2.22
- DRRX $0.85
- Analyst Decision
- GOVX Strong Buy
- DRRX Buy
- Analyst Count
- GOVX 5
- DRRX 2
- Target Price
- GOVX $14.20
- DRRX $5.00
- AVG Volume (30 Days)
- GOVX 759.4K
- DRRX 124.4K
- Earning Date
- GOVX 02-27-2025
- DRRX 11-13-2024
- Dividend Yield
- GOVX N/A
- DRRX N/A
- EPS Growth
- GOVX N/A
- DRRX N/A
- EPS
- GOVX N/A
- DRRX N/A
- Revenue
- GOVX $3,090,161.00
- DRRX $8,594,000.00
- Revenue This Year
- GOVX N/A
- DRRX $54.32
- Revenue Next Year
- GOVX $150.51
- DRRX N/A
- P/E Ratio
- GOVX N/A
- DRRX N/A
- Revenue Growth
- GOVX N/A
- DRRX N/A
- 52 Week Low
- GOVX $1.09
- DRRX $0.68
- 52 Week High
- GOVX $11.18
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- GOVX 44.57
- DRRX 47.88
- Support Level
- GOVX $2.04
- DRRX $0.79
- Resistance Level
- GOVX $2.32
- DRRX $0.86
- Average True Range (ATR)
- GOVX 0.18
- DRRX 0.08
- MACD
- GOVX -0.02
- DRRX 0.01
- Stochastic Oscillator
- GOVX 25.35
- DRRX 51.69
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .